Entering text into the input field will update the search result below

Alexandria Real Estate: Stable Dividend With An Expected Raise

Daniel P. Varga profile picture
Daniel P. Varga


  • More than 15% of the company’s total revenue comes from pharma and lab space rentals.
  • ARE is yielding 2.2% and I expect a dividend raise of 2-7% in 2022.
  • Q3 represented the second-highest leasing quarter of development and redevelopment square footage in the company’s history.
Bloomberg Speaks At Opening Of New York Genome Center

Andrew Burton/Getty Images News

Investment thesis

As the pandemic continues with different variants the healthcare and biotech sector can make great profits by developing new forms of vaccinations and pills against COVID-19 infections. Alexandria Real Estate Equities, Inc. (NYSE:ARE) has already taken its

This article was written by

Daniel P. Varga profile picture
Started investing more than 10 years ago. Mainly focusing on Large-Caps and occasional story stock. In addition, I am a regular buyer and analyzer of REITs, mREITS, and asset managers. I also have a dividend-focused portfolio with an investment horizon of 15 to 25 years. Follow me for comparison articles such as AAL vs. LUV or USB vs. C.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.